443 related articles for article (PubMed ID: 20573459)
21. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
22. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
23. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
24. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.
Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C
Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511
[TBL] [Abstract][Full Text] [Related]
25. Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment.
Fontaine J; Thomas L; Balme B; Ronger-Savle S; Traullé C; Petrella T; Dalle S
Clin Exp Dermatol; 2009 Jul; 34(5):e43-5. PubMed ID: 19508475
[TBL] [Abstract][Full Text] [Related]
26. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
27. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
[TBL] [Abstract][Full Text] [Related]
29. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
32. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
[TBL] [Abstract][Full Text] [Related]
34. [Blastic plasmacytoid dendritic cell neoplasm: report of a case].
Zhang H; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):710-1. PubMed ID: 22321557
[No Abstract] [Full Text] [Related]
35. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
36. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
[TBL] [Abstract][Full Text] [Related]
37. [Blastic plasmacytoid dendritic cell neoplasm: two cases report and review of literatures].
An G; Qi JY; Zou DH; Zhao YZ; Chen HS; Qiu LG
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):189-92. PubMed ID: 19576083
[TBL] [Abstract][Full Text] [Related]
38. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
Stokkermans-Dubois J; Jouary T; Vergier B; Delaunay MM; Taieb A
Dermatology; 2006; 213(4):345-9. PubMed ID: 17135744
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
40. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
